logo
GROTTO PHARMACEUTICALS PRIVATE LIMITED

ACTIVE

PRIVATE COMPANY

Grotto Pharmaceuticals Private Limited is a Private Company incorporated on 2005. It is classified as Non-govt company as a Company limited by Shares and is registered at Registrar of Companies, RoC-Delhi. Its authorized share capital is Rs. 100000.0 and its paid up capital is Rs. 100000.0. It is involved in Manufacturing (Metals & Chemicals, and products thereof) Grotto Pharmaceuticals Private Limited's Annual General Meeting (AGM) was last held on 2020-12-30 and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2020-03-31 Grotto Pharmaceuticals Private Limited's Corporate Identification Number is (CIN) U24232DL2005PTC137614 and its registration number is 137614


Basic Info

STATUS

ACTIVE

TYPE

PRIVATE COMPANY

PAID UP CAPITAL

₹1.00 lakh(s)

ADDRESS

K - 7B, GROUND FLOOR, KALKAJI NEW DELHI DL 110019 IN


Registrations

CIN

U24232DL2005PTC137614


Relationships

YASHVANT RAI

Director

Appointed on: 16 Aug 2008
12 Year(s) 5 Month(s)

GIRISH KUMAR SHARMA

Additional Director

Appointed on: 01 Jun 2011
9 Year(s) 8 Month(s)

PRIYANKA SRIVASTAVA

Director

Appointed on: 27 Aug 2018
2 Year(s) 5 Month(s)

MAHENDRA KUMAR SHRMA

Director

Appointed on: 21 Aug 2018
2 Year(s) 5 Month(s)

Get a

of
GROTTO PHARMACEUTICALS PRIVATE LIMITED for free now!

Leverage these reports for credit decisioning, competitor analysis, and supplier/vendor evaluation

Leverage these reports for credit decisioning, competitor analysis, and supplier/vendor evaluation

Comprehensive report with insights built on 50+ risk parameters and 2000+ public data sources

Comprehensive report with insights built on 50+ risk parameters and 2000+ public data sources

Used by leading banks and financial institutions in India

Used by leading banks and financial institutions in India

Leverage these reports for credit decisioning, competitor analysis, and supplier/vendor evaluation

Leverage these reports for credit decisioning, competitor analysis, and supplier/vendor evaluation

Comprehensive report with insights built on 50+ risk parameters and 2000+ public data sources

Comprehensive report with insights built on 50+ risk parameters and 2000+ public data sources